A carregar...
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer
Immunotherapy with PD‐1 and PD‐L1 inhibitors has revolutionized the treatment for patients with NSCLC the last years with increased overall survival and in particular increased number of long‐time survivors in patients with metastatic disease. It is now a treatment of choice for patients with distan...
Na minha lista:
| Publicado no: | Scand J Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757202/ https://ncbi.nlm.nih.gov/pubmed/33015859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/sji.12980 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|